New therapy that can be beneficial for lung cancer.

Cancer of the lung could be very bad and its the main reason why people who have cancer suffer from cancer of the lung in particular, patients that recently having an advance state of non small cell lung cancer which happen to be the most common type are treated by giving a mixture of different chemotherapy drugs as treatment. Nivolumab is a momoclonal antibody that's main aim is the immune system reaction to the disease, the drug nivolumab act as a protector or a path way and hinders the immune system from destroying the tumor.

The drug has a side effect and the latest when the drug was put to test is the inflammation of the thyroid and colon, thirty three percent of the patience with non small cell lung cancer did respond to treatment. Reports have it that the trials of the drug are still in process and could take a few more years before the study on human could be completed, relax back while you check back on us for the latest as pertaining to that.